AL
Alnylam Pharmaceuticals Inc.
ALNY · Alnylam Pharmaceuticals Inc. · Healthcare
Up next day
9/12
75%
Fell despite growth
3/12
Good earnings ignored
Avg earnings move
±1.9%
typical swing on earnings
Price when beating
+1.2%
avg over 7 beats
Biggest single move
+3.6%
'23.9 · largest reaction
How this stock reacts to earnings
Traits seen across its recent earnings reactions
Good results usually push the stock up
Up the next day 6 of 7 beats (86%)
Reaction is erratic and hard to predict
Avg +1.2% on a beat, +0.4% on a miss
vs Healthcare sector avg (153 peers)
This
+0.9%
Sector
+0.4%
Avg next-day reaction
Earnings number vs guidance — which drives it?
How often the beat/miss matched the actual price move
This stock mostly moves with the reported earnings number
Moved opposite to results 4 of last 12 times (33%)
1xBeat but fell
Even a beat sells off if guidance disappoints
3xMissed but rose
Even a miss rebounds if guidance reassures
Earnings timeline · tap a bar for that quarter
Oct 29Before open
'26.9 expectedEst. EPS $2.32
Quarter ended 6/2026
Reported 2026-07-30
Next-day move
+0.0%
After 5 days +5.2%
vs Consensus$2.14→$1.84-14.2% miss
EPS
$1.84
YoY +475%
Revenue
$1.3B
YoY +67%
Next-Q guidance
—
N/A
Price around earnings
-32% dip before
Earnings trend · last 12 quarters
EPS$1.84YoY +475%
'23.6'26.6
Revenue$1.3BYoY +67%
'23.6'26.6
Price vs earnings · last 12 quarters
↑Up↓Down
Bad news out
weak · up ↑
2x17%
Met expectations
good · up ↑
7x58%
Disappointment
weak · down ↓
0x
Good earnings ignored
good · down ↓
3x25%
← ← Weak earningsStrong earnings → →
Mostly 'honest' — good earnings, price up · 7 of 12q (58%)
Community · ALNY
What do you think of this stock's earnings pattern?
···